Roche Molecular Diagnostics
PLEASANTON, California, June 4, 2010 - Roche Molecular Diagnostics (SIX: RO, ROG: OTCQX: RHHBY) announced today
that the Food and Drug Administration (FDA) approved its new dual-PCR target
HIV-1 viral load test to quantify the amount of virus in a patient's blood.
PLEASANTON, California -
- New pre-analytical solution that integrates automated primary tube handling
Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today the availability of the cobas p 630 Instrument with CE Mark and the AMPLILINK 3.3 Series Software.
